vs
Side-by-side financial comparison of DELUXE CORP (DLX) and Bio-Techne (TECH). Click either name above to swap in a different company.
DELUXE CORP is the larger business by last-quarter revenue ($535.2M vs $295.9M, roughly 1.8× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 2.2%, a 10.6% gap on every dollar of revenue. On growth, DELUXE CORP posted the faster year-over-year revenue change (2.8% vs -6.4%). Over the past eight quarters, Bio-Techne's revenue compounded faster (4.2% CAGR vs 0.0%).
Deluxe Corporation is an American company that provides payment processing, data services, checks and promotional products, and merchant services. It operates in four divisions: B2B payments, data, print, and merchant services. As of 2025, the company serves millions of small businesses and thousands of financial institutions, processing more than $2.8 trillion in payments annually. While its legacy business centers on check printing and other printed products, payments and data services now ...
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
DLX vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $535.2M | $295.9M |
| Net Profit | $12.0M | $38.0M |
| Gross Margin | 52.2% | 64.6% |
| Operating Margin | 8.9% | 18.4% |
| Net Margin | 2.2% | 12.8% |
| Revenue YoY | 2.8% | -6.4% |
| Net Profit YoY | -5.0% | 68.3% |
| EPS (diluted) | $0.25 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $535.2M | $295.9M | ||
| Q3 25 | $540.2M | — | ||
| Q2 25 | $521.3M | $317.0M | ||
| Q1 25 | $536.5M | $316.2M | ||
| Q4 24 | $520.6M | $297.0M | ||
| Q3 24 | $528.4M | $289.5M | ||
| Q2 24 | $537.8M | $306.1M | ||
| Q1 24 | $535.0M | $303.4M |
| Q4 25 | $12.0M | $38.0M | ||
| Q3 25 | $33.7M | — | ||
| Q2 25 | $22.4M | $-17.7M | ||
| Q1 25 | $14.0M | $22.6M | ||
| Q4 24 | $12.6M | $34.9M | ||
| Q3 24 | $8.9M | $33.6M | ||
| Q2 24 | $20.5M | $40.6M | ||
| Q1 24 | $10.8M | $49.1M |
| Q4 25 | 52.2% | 64.6% | ||
| Q3 25 | 53.9% | — | ||
| Q2 25 | 53.6% | 62.7% | ||
| Q1 25 | 52.4% | 67.9% | ||
| Q4 24 | 52.3% | 65.3% | ||
| Q3 24 | 53.3% | 63.2% | ||
| Q2 24 | 53.7% | 66.4% | ||
| Q1 24 | 53.0% | 67.4% |
| Q4 25 | 8.9% | 18.4% | ||
| Q3 25 | 14.0% | — | ||
| Q2 25 | 11.7% | -7.5% | ||
| Q1 25 | 9.0% | 12.2% | ||
| Q4 24 | 9.0% | 16.0% | ||
| Q3 24 | 7.9% | 13.8% | ||
| Q2 24 | 11.0% | 15.0% | ||
| Q1 24 | 8.3% | 22.1% |
| Q4 25 | 2.2% | 12.8% | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 4.3% | -5.6% | ||
| Q1 25 | 2.6% | 7.1% | ||
| Q4 24 | 2.4% | 11.7% | ||
| Q3 24 | 1.7% | 11.6% | ||
| Q2 24 | 3.8% | 13.3% | ||
| Q1 24 | 2.0% | 16.2% |
| Q4 25 | $0.25 | $0.24 | ||
| Q3 25 | $0.74 | — | ||
| Q2 25 | $0.50 | $-0.11 | ||
| Q1 25 | $0.31 | $0.14 | ||
| Q4 24 | $0.28 | $0.22 | ||
| Q3 24 | $0.20 | $0.21 | ||
| Q2 24 | $0.46 | $0.26 | ||
| Q1 24 | $0.24 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.9M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $680.7M | $2.0B |
| Total Assets | $2.9B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.9M | $172.9M | ||
| Q3 25 | $25.8M | — | ||
| Q2 25 | $26.0M | $162.2M | ||
| Q1 25 | $30.3M | $140.7M | ||
| Q4 24 | $34.4M | $177.5M | ||
| Q3 24 | $41.3M | $187.5M | ||
| Q2 24 | $23.1M | $152.9M | ||
| Q1 24 | $23.5M | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $680.7M | $2.0B | ||
| Q3 25 | $664.1M | — | ||
| Q2 25 | $638.7M | $1.9B | ||
| Q1 25 | $622.5M | $2.0B | ||
| Q4 24 | $620.9M | $2.1B | ||
| Q3 24 | $612.7M | $2.1B | ||
| Q2 24 | $620.5M | $2.1B | ||
| Q1 24 | $608.4M | $2.0B |
| Q4 25 | $2.9B | $2.5B | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.5B | $2.6B | ||
| Q1 25 | $2.6B | $2.6B | ||
| Q4 24 | $2.8B | $2.7B | ||
| Q3 24 | $2.6B | $2.7B | ||
| Q2 24 | $2.7B | $2.7B | ||
| Q1 24 | $2.7B | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $102.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 8.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $102.1M | — | ||
| Q3 25 | $67.1M | — | ||
| Q2 25 | $51.1M | $98.2M | ||
| Q1 25 | $50.3M | $41.1M | ||
| Q4 24 | $60.2M | $84.3M | ||
| Q3 24 | $67.9M | $63.9M | ||
| Q2 24 | $39.6M | $75.5M | ||
| Q1 24 | $26.6M | $81.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $27.8M | $93.3M | ||
| Q1 25 | $24.3M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $46.7M | $54.7M | ||
| Q2 24 | $11.4M | $57.5M | ||
| Q1 24 | $6.1M | $64.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.3% | 29.4% | ||
| Q1 25 | 4.5% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | 8.8% | 18.9% | ||
| Q2 24 | 2.1% | 18.8% | ||
| Q1 24 | 1.1% | 21.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.5% | 1.5% | ||
| Q1 25 | 4.8% | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | 4.0% | 3.2% | ||
| Q2 24 | 5.2% | 5.9% | ||
| Q1 24 | 3.8% | 5.4% |
| Q4 25 | 8.53× | — | ||
| Q3 25 | 1.99× | — | ||
| Q2 25 | 2.28× | — | ||
| Q1 25 | 3.59× | 1.82× | ||
| Q4 24 | 4.77× | 2.42× | ||
| Q3 24 | 7.60× | 1.90× | ||
| Q2 24 | 1.94× | 1.86× | ||
| Q1 24 | 2.46× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DLX
| Services | $247.9M | 46% |
| B2B Payments | $76.3M | 14% |
| Datadrivenmarketingsolutions | $68.5M | 13% |
| Promotional Solutions Revenue | $60.9M | 11% |
| Treasurymanagementsolutions | $59.8M | 11% |
| Other | $17.3M | 3% |
| Other Web Based Solutions | $4.6M | 1% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
